Yamakita N, Murai T, Oki Y, Matsuhisa T, Hirata T, Ikeda T, Kuwayama A, Yasuda K
Department of Internal Medicine, Matsunami General Hospital, Kasamatsu, Gifu, Japan.
Endocr J. 2001 Feb;48(1):43-51. doi: 10.1507/endocrj.48.43.
A 15-year-old girl with Cushing's disease exhibited adrenal insufficiency following incomplete trans-sphenoidal resection of a large pituitary corticotropinoma, approximately 35 mm in diameter. Within two weeks following surgery, her plasma ACTH level decreased from 42 to 13 pmol/l, while, her plasma cortisol levels and urinary excretion of free cortisol decreased from 607 nmol/l and 1112 nmol/day to 94 nmol/l and 55 nmol/day, respectively. Immunoreactive ACTH was characterized in plasma using Sephadex G-75 column chromatography and measuring ACTH with immunoradiometric assay (IRMA) and radioimmunoassay (RIA) to determine additional peaks, other than the one demonstrated for 1-39 ACTH. In particular, when measured with RIA, a broad peak including the high molecular weight ACTH was detected as well as 1-39 ACTH. The bioactivity of the high molecular weight ACTH in patient plasma was lower than the reference range of 1-39 ACTH, which is determined by the ability of dispersed rat adrenocortical cells to secrete corticosterone. The large pituitary corticotropinoma found in this patient secreted not only 1-39 ACTH but also high molecular weight proopiomelanocortin (POMC)-derived peptides, which could be detected by measuring with IRMA and RIA for ACTH. Based on the results of biological activity and molecular ratios, no positive evidence could be found to support the hypothesis that the high molecular weight ACTH induced any postoperative adrenal insufficiency in this patient. However, based on this study, the possibility of adrenal insufficiency should be carefully monitored, even when post-operative remnant tumor tissue is clearly present in patients with Cushing's disease, accompanied by macrocorticotropinoma.
一名患有库欣病的15岁女孩,在经蝶窦入路不完全切除直径约35毫米的大型垂体促肾上腺皮质激素瘤后出现肾上腺功能不全。术后两周内,她的血浆促肾上腺皮质激素(ACTH)水平从42皮摩尔/升降至13皮摩尔/升,而血浆皮质醇水平和尿游离皮质醇排泄量分别从607纳摩尔/升和1112纳摩尔/天降至94纳摩尔/升和55纳摩尔/天。使用葡聚糖凝胶G - 75柱色谱法对血浆中的免疫反应性ACTH进行表征,并通过免疫放射测定法(IRMA)和放射免疫测定法(RIA)测量ACTH,以确定除1 - 39 ACTH所示峰之外的其他峰。特别是,当用RIA测量时,除了1 - 39 ACTH外,还检测到一个包含高分子量ACTH的宽峰。患者血浆中高分子量ACTH的生物活性低于1 - 39 ACTH的参考范围,该参考范围由分散的大鼠肾上腺皮质细胞分泌皮质酮的能力确定。该患者发现的大型垂体促肾上腺皮质激素瘤不仅分泌1 - 39 ACTH,还分泌高分子量阿黑皮素原(POMC)衍生肽,这可以通过用IRMA和RIA测量ACTH来检测。基于生物活性和分子比例的结果,没有发现阳性证据支持高分子量ACTH导致该患者术后肾上腺功能不全这一假设。然而,基于这项研究,即使库欣病伴有大促肾上腺皮质激素瘤的患者术后残留肿瘤组织清晰可见,也应仔细监测肾上腺功能不全的可能性。